Press release
Cancer Biomarkers Market Anticipated to Exceed USD 74.3 Billion by 2035
Cancer Biomarkers Market Anticipated to Exceed USD 74.3 Billion by 2035
MarketGenics, a global research and consulting firm, today announced its latest report on the Cancer Biomarkers Market, highlighting how early detection, liquid biopsy innovations, and AI-enabled diagnostics are driving the future of oncology care.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/cancer-biomarkers-market-00931
Market Outlook
The global cancer biomarkers market is anticipated to expand from USD 26.8 Billion in 2025 to USD 74.3 Billion by 2035, growing at a CAGR of 9.7%.
Growth is supported by:
Increasing demand for precise, early cancer detection.
Rapid advances in genomic, proteomic, and AI-driven biomarker platforms.
Expansion of liquid biopsy adoption, reducing reliance on invasive procedures.
Rising investments from governments and cancer foundations in national screening programs.
Biomarkers are becoming a cornerstone of personalized medicine, empowering clinicians to tailor treatments, monitor therapy response, and predict recurrence with higher accuracy.
Industry Developments
New Biomarker Launches (2024) - Multiple blood-based biomarkers adopted across North America, Europe, and Asia for less invasive cancer testing.
AI-Driven Digital Pathology - Tools enabling pathologists to extract and analyze biomarkers quickly, addressing workforce shortages in hospitals.
Funding Momentum - National screening programs and educational campaigns expanding biomarker adoption in oncology guidelines.
Market Dynamics
Drivers - Rising cancer incidence, demand for personalized medicine, integration of biomarkers into targeted therapy and companion diagnostics.
Restraints - Lack of testing standardization, limited reimbursement in some regions, and regulatory bottlenecks slowing assay approvals.
Opportunities - Liquid biopsy expansion, AI-enabled biomarker analysis, and multi-omics integration for more comprehensive tumor insights.
To know more about the Cancer Biomarkers Market - Download our Sample Report: https://marketgenics.co/download-report-sample/cancer-biomarkers-market-00931
Impact of Global Tariff Regulations
The cancer biomarkers market is sensitive to tariffs on diagnostic kits, reagents, and sequencing platforms:
High tariffs increase costs for hospitals and patients, especially in low- and middle-income regions.
Trade restrictions delay adoption of advanced biomarker tools.
Exemptions during public health campaigns improve access and encourage broader implementation of biomarker testing in national cancer programs.
Global tariff policies thus play a pivotal role in shaping affordability and adoption pathways for biomarker diagnostics.
Expansion of the Cancer Biomarkers Market
"Accelerating Growth Driven by Early Detection, Precision Medicine, and Technological Progress"
The market is experiencing strong momentum through:
Liquid biopsies for non-invasive early detection.
AI and machine learning for faster, more accurate biomarker data analysis.
Government funding and clinical guideline integration supporting biomarker adoption in mainstream oncology.
Cancer biomarkers are now central to therapy monitoring, drug discovery, and recurrence prediction, reinforcing their position in precision oncology ecosystems worldwide.
Get the Detailed Industry Analysis (including the Table of Contents, List of Figures, and List of Tables) - from the Cancer Biomarkers Market Research Report: https://marketgenics.co/press-releases/cancer-biomarkers-market-00931
Regional Analysis
North America - Largest market due to high cancer incidence, strong R&D, and early adoption of precision medicine. U.S. biotech firms and cancer centers lead biomarker innovations.
Europe - Rapid uptake in hospital systems and national screening programs, supported by strong regulatory guidance.
Asia Pacific - Fastest-growing region, with governments in India, China, and Japan funding early cancer detection initiatives. Growth challenged by test costs and workforce gaps in some nations.
Middle East & Africa - Early-stage adoption, with government initiatives beginning to integrate biomarkers into public health frameworks.
South America - Steady growth as healthcare systems improve access to advanced diagnostics.
Key Players in the Cancer Biomarkers Market
Abbott Laboratories, Agilent Technologies, Amgen Inc., AstraZeneca plc, Becton Dickinson & Company (BD), Bio-Rad Laboratories, Bristol-Myers Squibb, Eurofins Scientific, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., GE Healthcare, Guardant Health Inc., Illumina Inc., Merck & Co. Inc., Myriad Genetics Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and other key players.
About Us
MarketGenics is a global market research and management consulting company empowering decision makers across healthcare, technology, and policy domains. Our mission is to deliver granular market intelligence combined with strategic foresight to accelerate sustainable growth.
We support clients across strategy development, product innovation, healthcare infrastructure, and digital transformation.
Contact:
Mr. Debashish Roy
MarketGenics India Pvt. Ltd.
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Anticipated to Exceed USD 74.3 Billion by 2035 here
News-ID: 4186133 • Views: …
More Releases from MarketGenics India Pvt. Ltd.
Biosimilars Market Anticipated to Exceed USD 125.9 Billion by 2035
Biosimilars Market projected to grow at a CAGR of 13.4% during the forecast period of 2025 to 2035
MarketGenics, a global market research and consulting company, has released its latest study on the biosimilars market, spotlighting the role of patent expiries, affordability needs, and supportive regulatory frameworks in fueling rapid adoption worldwide.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/biosimilars-market-04169
Market Outlook
The global biosimilars market is expected to expand…
Precision Oncology Market Likely to Reach USD 317.5 Billion by 2035
Precision Oncology Market projected to grow at a CAGR of 7.8% during the forecast period of 2025 to 2035
MarketGenics, a leading market intelligence and consulting company, today announced its latest research report on the global precision oncology market, highlighting how rapid advances in genomics, AI-driven profiling, and targeted therapies are reshaping cancer care.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/precision-oncology-market-55206
The study underscores the integration of multi-omics,…
Remote Patient Monitoring Market Likely to Reach USD 88.3 Billion by 2035
Remote Patient Monitoring Market projected to grow at a CAGR of 11.7% during the forecast period of 2025 to 2035
MarketGenics, a leading healthcare research and strategy consulting firm, has unveiled new insights on the rapidly expanding Remote Patient Monitoring (RPM) market, which is revolutionizing patient care delivery worldwide.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/remote-patient-monitoring-market-75172
The market study highlights how aging populations, chronic disease prevalence, and AI-powered…
Telemedicine Market Likely to Reach USD 279.9 Billion by 2035
Telemedicine Market projected to grow at a CAGR of 12.3% during the forecast period of 2025 to 2035
MarketGenics, a leading player in healthcare research and digital health innovation, announced groundbreaking insights into the rapidly expanding global telemedicine market.
Get the complete market breakdown - statistics, insights, and future outlook: https://marketgenics.co/reports/telemedicine-market-93408
The market study highlights the intersection of innovation, equity, and technological acceleration reshaping the telehealth industry worldwide.
Recent Investments & Initiatives
AI Telehealth Rollout…
More Releases for Biomarker
Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Multiplex Biomarker Imaging Market Size By 2025?
In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of…
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints),
Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,…
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA.
Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register
MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference:
Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge…
Biomarker Testing Market | Agilent Technologies, Roche, ,
The global biomarker testing market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the biomarker testing market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being.
CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,…
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558
This latest report researches the industry structure,…
